OP 8.5 – 00104 TGF-beta Blockade to Stop HIV White Noise: a New “Release and Kill” HIV Strategy

OP 8.5 – 00104 TGF-beta Blockade to Stop HIV White Noise: a New “Release and Kill” HIV Strategy

Bibliographic Details
Main Authors:	E. Martinelli, M.R. Haque, J. Kim, S. Samer, Y. Thomas, D. Bose, B. Keele, R. Lorenzo-Redondo, T.J. Hope, F.J. Villinger
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664022002175

Similar Items

PM00104 (Zalypsis®): A Marine Derived Alkylating Agent
by: Bradley J. Petek, et al.
Published: (2014-08-01)

Blockade of TGF-β signaling reactivates HIV-1/SIV reservoirs and immune responses in vivo
by: Sadia Samer, et al.
Published: (2023-06-01)

OP 2.2 – 00200 Characterization of the SIV tissue reservoir transcriptional environment at the single focus level during ART and post ATI
by: M. Arif, et al.
Published: (2022-12-01)

ZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell lines.
by: Zhenfeng Duan, et al.
Published: (2009-09-01)

TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivo
by: Jinhee Kim, et al.
Published: (2024-02-01)

Curing HIV by 'kick and kill': from theory to practice?
by: Pace, M, et al.
Published: (2019)

HIV-1 protection: Antibodies move in for the kill
by: Zak A. Yaffe, et al.
Published: (2021-10-01)

How to stop your doctor killing you /
by: 400686 Coleman, Vernon
Published: (1996)

HIV: Bad news for stop--start therapy?
by: Mcmichael, A, et al.
Published: (2002)

PD-1 blockade boost vaccine-induced anti-HIV responses in the absence of HIV reactivation
by: J.G. Prado, et al.
Published: (2019-12-01)

Modeling Kick-Kill Strategies toward HIV Cure
by: Esteban A. Hernandez-Vargas
Published: (2017-08-01)

Editorial: Stop Killing Healthcare Workers in South Sudan
by: Edward Eremugo Kenyi
Published: (2021-08-01)

How to unleash mitochondrial apoptotic blockades to kill cancers?
by: Jing Deng
Published: (2017-01-01)

OP 1.2 – 00157 HIV Silencing and Cell Survival Signatures of HIV-Infected CD4 T Cell Transcriptomes under Antiretroviral Therapy (ART)
by: I.C. Clark, et al.
Published: (2022-12-01)

27 HIV-associated gastrointestinal microbial dysbiosis influences the efficacy of anti-HIV immunity by immune checkpoint blockade
by: I.N. SahBandar, et al.
Published: (2017-07-01)

Landscape review of current HIV ‘kick and kill’ cure research - some kicking, not enough killing
by: Kristian Thorlund, et al.
Published: (2017-08-01)

OP 1.1 Sequencing HIV: Significance and Impact
by: S. Palmer
Published: (2022-12-01)

OP 3.1 HIV Persistence in women, an update
by: N. Archin
Published: (2022-12-01)

Photoinduced Photosensitizer–Antibody Conjugates Kill HIV Env-Expressing Cells, Also Inactivating HIV
by: Mohammad Sadraeian, et al.
Published: (2021-06-01)

OP 1.10 – 00210 Clonal Dynamics within HIV-Infected CD4 T Cell Reservoirs after PD-1 Blockade under ART
by: L. Perez, et al.
Published: (2022-12-01)

α4β7-blockade delays viral rebound in SHIV infected macaques treated with a combination of HIV bNAbs
by: E. Martinelli
Published: (2019-12-01)

Intrinsic resistance of HIV-infected macrophages to CTL-mediated killing drives immune activation
by: K. Clayton, et al.
Published: (2017-12-01)

Nanobody‐mediated complement activation to kill HIV‐infected cells
by: Maria Lange Pedersen, et al.
Published: (2023-04-01)

Prime, shock and kill: BCL-2 inhibition for HIV cure
by: Aswath P. Chandrasekar, et al.
Published: (2022-10-01)

Role of Dendritic Cells in Exposing Latent HIV-1 for the Kill
by: Jan Kristoff, et al.
Published: (2019-12-01)

OP 2.8 – 00193 Enhancing PKC Modulator HIV Latency Reversing Agents
by: M. Marsden, et al.
Published: (2022-12-01)

Farmers kill 23 million birds to stop influenza virus
by: Charlene Crabb

TIGIT Blockade: A Multipronged Approach to Target the HIV Reservoir
by: Kayla A. Holder, et al.
Published: (2020-05-01)

OP 2.1 CCR5 in HIV Prevention and Cure
by: Helen L. Wu, et al.
Published: (2022-12-01)

Comparative efficiency of HIV-1-infected T cell killing by NK cells, monocytes and neutrophils.
by: Adjoa Smalls-Mantey, et al.
Published: (2013-01-01)

Verstoorde microcirculatie en verhoogde bloedsuikerwaarde verhogen kans op depressie op latere leeftijd
by: Anouk F.J. Geraets
Published: (2021-08-01)

Soeklig op die Klerksdorp-kompleks
by: F.J. Potgieter
Published: (1969-03-01)

Infected cell killing by HIV-1 protease promotes NF-kappaB dependent HIV-1 replication.
by: Gary D Bren, et al.
Published: (2008-05-01)

The dynamics of T and B cells in lymph node during chronic HIV infection: TFH and HIV, unhappy dance partners?
by: Jung Joo Hong, et al.
Published: (2016-11-01)

B cell responses to HIV antigen are a potent correlate of viremia in HIV-1 infection and improve with PD-1 blockade.
by: Katherine J Nicholas, et al.
Published: (2013-01-01)

TB or not TB? Difficulties in the diagnosis op tuberculosis in HIV-negative immigrants to Germany
by: Singh DD, et al.
Published: (2011-09-01)

Lnc(ing)RNAs to the “shock and kill” strategy for HIV-1 cure
by: Saikat Boliar, et al.
Published: (2021-03-01)

Sting agonist as a kick and kill agent to target the HIV reservoir
by: M. Mavigner, et al.
Published: (2019-07-01)

Targeted cytotoxic therapy kills persisting HIV infected cells during ART.
by: Paul W Denton, et al.
Published: (2014-01-01)

Preclinical development of a bispecific HIV x CD3 DART molecule that redirects T cells to kill HIV envelope (env)-expressing cells
by: J.L. Nordstrom, et al.
Published: (2017-12-01)